Central serotonergic system and mechanism of anxiolytic action

Acta Physiologica Hungarica

Volumn 84, Issue 4, 1996, Pages 449-451

  Plaznik, A ^a   Stefanski R ^a   Jessa, M ^a   Nazar, M ^a   Bidzinski A ^a  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Anxiolytic action; Benzodiazepines; Central serotonergic system

Indexed keywords

ANXIOLYTIC AGENT; SEROTONIN; SEROTONIN AGONIST; SEROTONIN ANTAGONIST;

ANIMAL; ARTICLE; CONFLICT; DRUG EFFECT; ELECTRIC SHOCK; HIPPOCAMPUS; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; PHYSIOLOGY; RAT;

ANIMALS; ANTI-ANXIETY AGENTS; CONFLICT (PSYCHOLOGY); ELECTROSHOCK; HIPPOCAMPUS; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; RATS; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 2842538081     PISSN: 0231424X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Carli, M., Samanin, R.: Potential anxiolytic properties of 8-OH-DPAT a selective serotonin 1A receptor agonist. Psychopharmacol., 1988, 94, 84-91.
2. De Vry, J., Glaser, T., Schuurman, T , Schreiber, R., Traber, J.: 5-HT1A receptors in anxiety. In. New Concepts in Anxiety (Briley, M. and File, S. E , Eds.). MacMillan Press, London, pp. 94-129, 1991.
3. Gray, J. A : Precis of the neuropsychology of anxiety: an enquiry into the functions of the septo-hippocampal system. Behav. Brain Sci., 1982, 5, 469-534.
4. Hensler, J G , Kovadich, G B., Frazer, A : A quantitative autoradiographic study of serotonin 1A receptor regulation. Effect of 5,7-DHT and antidepressant treatments. Neuropsychopharmacol., 1991, 4, 131-144.
5. Hirose, A., Sasa, M., Akaike, A , Takaori, S : Inhibition of hippocampal CA1 neurons by 5-HT, derived from the dorsal raphe nucleus and the 5-HT1A agonist SM-3997. Neuropharmacol., 1990, 29, 93-101.
6. Papez, J. W.: A proposed mechanism of emotions. Archs. Neurol., 1937, 38, 725-743.
7. Schreiber, R., De Vry, J.: 5-HT1A receptor ligands in animal models of anxiety, impulsivity and depression: multiple mechanisms of action. Prog. Neuro-Psychopharmacol. Biol Psychiat., 1993, 17, 87-104
8. Stefanski, R., Palejko, W., Kostowski, W., Plaznik, A : The comparison of benzodiazepine derivatives and serotonergic agonists and antagonists in two animal models of anxiety Neuropharmacol., 1992, 31, 1251-1258
9. Stefanski, R , Palejko, W., Bidzinski, A., Kostowski, W., Plaznik, A.: Serotonergic innervation of the hippocampus and nucleus accumbens septi and the anxiolytic-like action of midazolam and 5-HT1A receptor agonists. Neuropharmacol., 1993, 32, 977-985.
10. Stefanski, R., Palejko, W , Bidzinski, A., Kostowski, W., Plaznik, A : Serotonergic innervation of the hippocampus and nucleus accumbens septi and the anxiolytic-like action of the 5-HT3 receptor antagonists. Neuropharmacol., 1993, 32, 987-993.
11. Treit, D.: 5-HT1A, 5-HT3 Antagonists and Benzodiazepines; Their Comparative Behavioural Pharmacology, R. J. Rodgers and S. J. Cooper (Eds). Wiley, Chichester, 1991, pp. 107-131
12. Wada, Y., Nakamura, M., Hasegawa, H., Yamaguchi, N.: Intra-hippocampal injection of 8-OH-DPAT inhibits partial and generalized seizures induced by kindling stimulation in cats. Neurosci. Lett., 1993, 159, 179-182.
13. Whitton, P., Curzon, G.: Anxiogenic-like effect of infusing mCPP into the hippocampus Psychopharmacol., 1990, 100, 138-140
14. Zifa, E., Fillion, G.: 5-Hydroxytryptamine receptors. Pharmacol. Rev., 1992, 44, 401-458